PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Apr-2024 Medical Simulation Market Projected To Reach USD 10634.2 Million By 2033, With CAGR Of 15.4% Wired Release
04-Apr-2024 Notice of Annual General Meeting of Vicore Pharma Holding AB (publ) AccessWire
04-Apr-2024 AlzeCure Pharma Publishes its Annual Report for 2023 AccessWire
04-Apr-2024 Genflow Biosciences PLC Announces Successful Placing and Subscription AccessWire
04-Apr-2024 Medartis successfully places CHF 115.8 million convertible bonds due 2031 Medartis Holding AG
03-Apr-2024 Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC Nxera Pharma
03-Apr-2024 Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence Agilent Technologies
03-Apr-2024 Precision Oncology Innovator SimBioSys and General Inception Announce Strategic Partnership to Accelerate Cancer Drug Development SimBioSys, Inc.
03-Apr-2024 EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowel Syndrome (IBS) EnteroBiotix Limited
03-Apr-2024 Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio Genmab A/S
03-Apr-2024 Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials Lindus Health
03-Apr-2024 Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting Astex Pharmaceuticals
03-Apr-2024 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024 ADC Therapeutics
03-Apr-2024 Largest ever UK health research programme to benefit from Novartis’ multi-million pound investment Novartis
03-Apr-2024 AlzeCure presents new data regarding the TrkA-NAM pain project at IASP 2024 AlzeCure Pharma AB
03-Apr-2024 Veeva Vault CRM Now Available for All New Customers Veeva Systems
03-Apr-2024 Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy Harmonic Discovery
03-Apr-2024 Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs Bespak
03-Apr-2024 Solventum Begins Trading on the New York Stock Exchange Solventum
03-Apr-2024 CNX Therapeutics to expand CNS portfolio through the acquisition of two established brands from Eisai CNX Therapeutics Limited